News

Managed Healthcare Executive4h
Chronic Itch Often Overlooked as New Treatments Face Coverage Hurdles
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Arcutis Announces Chief Financial Officer Transition
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that David Topper, ...
American Association of Individual Investors7h
Why Arcutis Biotherapeutics, Inc.’s (ARQT) Stock Is Down 11.05%
Arcutis Biotherapeutics, Inc.’s ARQT share price has dipped by 11.05%, which has investors questioning if this is right time ...
Medical Dialogues21h
Uveitis Risk Higher in Children with Early-Onset Atopic Dermatitis, Study Finds
The study found that children with early-onset AD had nearly twice the risk of developing uveitis (hazard ratio [HR] 1.92) ...
420 With CNW - Study Finds CBD, CBG-Infused Ointment Effective Against Eczema
A recent study has found that a skin ointment containing cannabigerol (CBG) and cannabidiol (CBD) may help ease the symptoms of atopic dermatitis, c ...